-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Is Canopy Growth a Buy After its Announcement to Cut Costs?
CGC stock has delivered losses for two years despite cannabis legalization on Canada. The company will not generate profits soon.
Why Is Sundial Growers (SNDL) Stock in the Spotlight Today?
The Canadian cannabis producer's stock is in focus today following quarterly results that show an improving picture at the company.
Investors Should Buy Tilray Stock as Legalization Approaches
A Congress nervous about upcoming midterms could pave the way for marijuana legalization. TLRY stock tends to perform well during such news.
Upcoming Earnings Report May Fail to Save the Day for Sundial Stock
Instead of buying ahead of or after earnings, wait for a reverse split before buying. It may result in shares plunging to a discount to tangible book, making SNDL stock both a value play and a moonshot play.
Money Invested in Tilray Is Likely to Go up in Smoke
TLRY stock continues to struggle with weak sales, declining market share and a U.S. market that remains off limits.
Cannabis Stocks Alert: Why Are SNDL, CURLF, TCNNF, GRWG, CLVR Stocks on Watch?
Cannabis stocks are looking to rebound today following yesterday's surprise downturn for pot companies. Here's what you need to know!
Sadly for Canopy Growth, the Fed Is on a Different Kind of High
With no foreseeable legal catalysts and a rough economic environment, CGC stock will likely face pressure for the next few months.
Cannabis Stocks Alert: Why Are SNDL, CLVR, TLRY, CGC, LFLY Stocks on Watch Today?
Traditionally in the U.S., April 20 is viewed as a holiday which celebrates marijuana. As a result, cannabis stocks are in focus.
Happy 420 Day! Buy This Top Pot Stock Now to Celebrate Later.
In celebration of 420 day, this top pot stock could be a surprise winner later as it focuses on streamlining its business.
As Pot Reform News Fades, Avoid Canopy Growth Stock
If you asked me to summarize my take on CGC stock, it may sound cliché, but to borrow a popular phrase somewhat related to this topic, I would reply, "just say no."
Blockbuster Clinical Results Shine a Positive Light on Sunshine Biopharma
An SEC filing may have deterred some traders from holding SBFM stock. However, a closer look at the facts should clear up any confusion.
Luke Lango Explains Opendoor Stock
What's the difference between OPEN and pot stocks? In short, economies of scale. Opendoor stock is a much better opportunity than anything in the cannabis arena.
Sundial: A Surprise Winner as Cannabis Legalization Hits Setback
Fading marijuana legalization hopes have the sector seeing red. However, SNDL stock could buck the broader industry downtrend.
Tilray Stock Should Recover Its Footing in Due Time
The business opportunity provided by Tilray is still bright, meanwhile the TLRY stock has already gone through a lifetime of whipsaws.
Canopy Growth: The Bearish Trend Is Not Expected to Relieve
The profitless cannabis business is poised for further downside due to weakening financials and a poor outlook.
Technical Indicators Turn Bullish for Sundial
CEO Zach George has said that one of the company’s financial goals is to have a positive cash flow by 2022, making SNDL stock a value play.
Tilray Stock Is Stuck In Neutral Until Cash Flow Turns Positive
TLRY stock is in the doldrums and could stay that way until Tilray can figure out how to produce positive free cash flow selling cannabis.
TLRY, HEXO Stocks: 7 Things to Know as Canadian Cannabis Kings Join Forces
Canadian cannabis companies Tilray (TLRY) and Hexo (HEXO) are teaming up to better tackle the marijuana market and their stocks are rising!